4.6 Review

PERK in beta cell biology and insulin biogenesis

Journal

TRENDS IN ENDOCRINOLOGY AND METABOLISM
Volume 21, Issue 12, Pages 714-721

Publisher

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tem.2010.08.005

Keywords

-

Funding

  1. NIDDK NIH HHS [R01 DK062049-03, R01 DK062049, R01 DK088140] Funding Source: Medline

Ask authors/readers for more resources

PERK (EIF2AK3) was originally discovered as a major component of the unfolded protein response (UPR). PERK deficiency results in permanent neonatal diabetes, which was initially thought to be caused by a failure to regulate ER stress in insulin-secreting beta cells, culminating in beta cell death. However, subsequent studies found that low beta cell mass was a result of reduced cell proliferation, rather than increased apoptosis. Genetic and cellular studies of Perk-deficient beta cells showed that PERK was crucially required for ER functions including proinsulin trafficking and quality control, unrelated to the ER stress pathway. Under normal physiological conditions, changes in ER calcium levels, mediated by glucose and other insulin secretagogues, regulate PERK activity for the purpose of controlling insulin biogenesis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available